Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 23 May, 2014 and appeared in  CardiovascularIssue 730

AACE: Prediabetes Guidelines for Lipids and Blood Pressure Levels

Call for guidelines for prediabetes from the Clinical Endocrinologists meeting....

Advertisement

While the American Association of Clinical Endocrinologists (AACE) guidelines for diabetes prevention offer an HbA1c goal of normoglycemia when a patient is in the range of prediabetes, AACE presented a call for additional guidelines in lipids and blood pressure when treating patients with prediabetes.

Leigh Perreault, MD, associate professor of medicine at the University of Colorado Anschutz Medical Campus, stated during her presentation at the AACE 23rd Annual Scientific & Clinical Congress that, currently, "there are no guidelines anywhere for exactly what our goals should be for lipids or for blood pressure for these people." "We should come together as a community to create these guidelines because there are so many people out there who could probably benefit."

Perreault presented extensive data supporting the AACE guidelines that instruct physicians to aim for normoglycemia in patients with prediabetes. The Diabetes Prevention Program, she explained, showed that when patients in the range of prediabetes returned to normoglycemia at any given point over the 10 years of observation, their risk of transitioning to diabetes was reduced. If they returned to normoglycemia more than once, they further reduced their risk.

"If we set that goal as normal glucose regulation, we can reduce their risk tremendously, up to 70% for people in whom we can actually get them there and keep them there," Perreault said."The good news from this analysis is it didn't matter how people got to normal, as long as people got to normal. This is a change, a shift in our paradigm, a rethinking of diabetes care or diabetes prevention."

This shift should also encompass reducing the cardiovascular risk of these patients with prediabetes, she said.

"There are data showing we can reduce cardiovascular risk factors and cardiovascular risk in people with prediabetes by treating them," Perreault said. "People can get complications of diabetes even if they never develop diabetes. People with prediabetes can get these complications. And the prevention of diabetes, particularly if [normoglycemia] can be achieved, is key and the risk reduction of cardiovascular disease might be right behind it."

Therefore, there is need to consider the lipid profile and blood pressure levels and create guidelines for the best management of patients with prediabetes.

Perreault L. W22. Presented at: AACE 23rd Annual Scientific & Clinical Congress; May 13-18, 2014; Las Vegas, Nevada.  

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 23 May, 2014 and appeared in  CardiovascularIssue 730

Past five issues: Diabetes Clinical Mastery Series Issue 206 | SGLT-2 Inhibitors Special Edition September 2014 | Issue 746 | Diabetes Clinical Mastery Series Issue 205 | Humulin Insulin Special Edition September 2014 |

2014 Most Popular Articles:

Abbott Announces Approval of Its New Unique Continuous Glucose Monitor
Posted September 05, 2014
Diabetic Neuropathy Improved with Vegan Diet
Posted August 22, 2014
Low Carb Beats Low Fat
Posted September 05, 2014
CDC: 40% of American Adults Will Develop Diabetes
Posted August 22, 2014
Empagliflozin (Jardiance) SGLT-2 Inhibitor Now Available in Pharmacies
Posted August 29, 2014
Lilly's Basal Insulin Peglispro Demonstrated HbA1c Superiority against Lantus
Posted September 05, 2014
New Ultra-Rapid-Acting Insulin Formulation
Posted August 22, 2014
Pistachios Associated with an Improved Metabolic Risk Profile in Prediabetes
Posted August 29, 2014
FDA Approves J&J's Invokamet Combo (SGLT-2 + Metformin)
Posted August 15, 2014
Sensor Implant Measures Blood pH in Type 1 Diabetes
Posted August 29, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Diabetes in Control is considering launching a store tab on the site with the ability to purchase A1C tests and other diagnostic test in bulk for medical professionals. What do you think?
CME/CE of the Week
Marie Williams, DPM

Category: Wound Care
Credits: .75



Search Articles On Diabetes In Control